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Purpose: The aim of this study was to evaluate the validity of a new pictorial form of a screening 
test for obstructive sleep apnea syndrome (OSAS) – the pictorial Sleepiness and Sleep Apnoea 
Scale (pSSAS). Validation was performed in a sample of patients admitted to sleep clinics in 
the UK and Switzerland.
Patients and methods: All study participants were investigated with objective sleep tests 
such as full-night-attended polysomnography or polygraphy. The pSSAS was validated by taking 
into account the individual result of the sleep study, sleep-related questionnaires and objective 
parameters such as body mass index (BMI) or neck circumference. Different scoring schemes 
of the pSSAS were evaluated, and an internal validation was undertaken.
Results: The full data set consisted of 431 individuals (234 patients from the UK, 197 patients 
from Switzerland). The pSSAS showed good predictive performance for OSAS with an area under 
the curve between 0.77 and 0.81 depending on which scoring scheme was used. The subscores 
of the pSSAS had a moderate-to-strong correlation with widely used screening questionnaires 
for OSAS or excessive daytime sleepiness as well as with BMI and neck circumference.
Conclusion: The pSSAS can be used to select patients with a high probability of having OSAS. 
Due to its simple pictorial design with short questions, it might be suitable for screening in 
populations with low health literacy and in non-native English or German speakers.
Keywords: questionnaire, excessive daytime sleepiness, sleep associated disorders, screening, 
pictorial, occupation
Introduction
Obstructive sleep apnea syndrome (OSAS) is characterized by repetitive episodes of 
total and/or partial pharyngeal collapse during sleep.1 Obesity and age are the best-
documented risk factors for this condition.2 OSAS is estimated to affect 2–15% of 
middle-aged adults, many of them remaining undiagnosed and untreated.3–5
OSAS may disturb sleep architecture leading to fragmented or decreased sleep 
duration, which results in excessive daytime sleepiness (EDS) and disturbance of 
concentration. It is associated with high rates of morbidity and mortality mostly due 
to cardiovascular diseases.2,6–8 Individuals with OSAS have a six- to sevenfold risk of 
having a road traffic crash and have an increased risk of cognitive dysfunction, depres-
sion and insomnia compared to those without OSAS.9,10
The Adult Obstructive Sleep Apnea Task Force of the American Academy of Sleep 
Medicine (AASM) has recommended incorporating questions regarding obstructive 
sleep apnea into routine health evaluations. The diagnostic strategy for OSAS in 
suspicious patients includes a sleep-oriented history and physical examination and 
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objective testing.11 There is no consensus in the American 
Sleep Association or the AASM about how to screen for 
OSAS by means of questionnaires.12
Mild degrees of OSAS can be treated by lifestyle modi-
fications such as weight loss, abstinence from alcohol/smok-
ing and use of sleep-inducing drugs and tranquilizer.11,13,14 
Continuous positive airway pressure (CPAP) treatment is 
considered the best treatment option for those with moderate-
to-severe OSAS and has been shown to decrease fatal and 
nonfatal cardiovascular events, normalize driving and atten-
tion performances in drivers and reduce overall mortality.11
Written questionnaires can be difficult for some patients 
to complete, and studies have shown that impaired health 
literacy is common in patients attending a sleep clinic.15 In 
addition to the effect of increased sleepiness, verbal episodic 
memory can be impaired in patients with OSAS.16 This led 
to the development of a pictorial Epworth Sleepiness Scale 
(pESS) in 2011, and the same team further developed a 
pictorial Sleepiness and Sleep Apnoea Scale (pSSAS) ques-
tionnaire that consists of eight items to be used for OSAS 
screening, four common to the pESS and four related to 
body morphology, blood pressure and witnessed apnea.17–21
The aim of this study was to develop the pSSAS scoring 
system to discriminate individuals with or without OSAS 
with a sensitivity and specificity of 80%. For this, we used 
data of patients with different risk levels for OSAS referred 
to sleep clinics in the UK and Switzerland.
Methods
The pSSaS questionnaire
The original pSSAS was established for an English-speaking 
population at the Imperial Sleep Centre at Charing Cross 
Hospital in London.18 It is self-administered by the patient 
and contains eight items (Figure 1A and B). Items 1–4 are 
used to evaluate EDS and are taken from the pESS.17 The 
pictograms show a person in various situations, in particular 
sitting and reading, watching TV or listening to the radio, 
sitting quietly after a meal or as a passenger in a car or bus. 
For each situation, the patient can choose five different 
integers. Items 5–8 are used to evaluate the risk factors and 
adverse outcomes of OSAS such as body size, neck size, 
blood pressure and witnessed pauses while breathing when 
asleep. Items 1–6 use a Likert scale with five answers, and 
item 7 allows the individual to choose from four and item 8 
from two possible answers. The patient is instructed to select 
the situation that he/she judges to best represent his/her situ-
ation. Details regarding translation and changes in the design 
of the German version of the pSSAS as well as the suggested 
scoring scheme can be found in the Supplementary material.
Patient study groups
For this study, the pSSAS was administered between February 
2010 and May 2012 to four groups of patients: A) patients 
examined for OSAS at Charing Cross Hospital, London, 
UK (Imperial College Healthcare NHS Trust); B) patients 
examined for OSAS at the sleep clinic of the Barmelweid 
Clinic, Barmelweid, Switzerland; C) patients admitted to 
the emergency department at the University Hospital Basel, 
Basel, Switzerland, for treatment and investigation after an 
occupational injury; and D) outpatients referred to the surgi-
cal outpatient or the occupational medicine department at the 
University Hospital Basel, Basel, Switzerland, for reasons 
other than injuries due to occupational accidents.
Questionnaires
For all patients, age, gender, height and weight were recorded. 
Each patient completed the English or German pSSAS as well 
as the English or German version of the ESS.22 Patients of 
groups B–D also answered the German version of the Sleep 
Apnea Scale of the Sleep Disorders Questionnaire (SA-
SDQ).23 A total of n=26 individuals from patient groups A 
and B were asked to fill in the pSSAS a second time (retest) 
before a treatment was initiated.
Scoring of sleep studies and attribution of 
OSaS diagnosis
The diagnosis of OSAS was based on an overnight sleep 
study. Information regarding scoring of sleep studies can be 
found in the Supplementary material. Regarding the pres-
ence of OSAS, the following criteria were considered in this 
study: No OSAS if apnea–hypopnea index (AHI) <5 or AHI 
5–14 and ESS score <10; OSAS if AHI ≥15 or AHI 5–14 
and ESS score ≥10.
pSSaS scoring scheme
Table 1 shows the three different scoring schemes which 
were evaluated. They differ in the scoring of pSSAS items 
7 and 8.
Statistical analysis
Only patients with no missing values in the pSSAS were 
included in the full analysis set. Descriptive statistics of 
demographic and baseline characteristics were calculated for 
the four patient groups separately and for the full analysis set. 
The performance of the different pSSAS scoring schemes in 
predicting OSAS was investigated by fitting separate single-
predictor logistic regression models. For each pSSAS scoring 
scheme, the area under the receiver operating characteristic 
(ROC) curve (AUC) was determined. Since the three ROC 
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A
Figure 1 (continued)
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B
Figure 1 (A) english and (B) german version of the pictorial Sleepiness and Sleep apnoea Scale questionnaire.
Notes: The english version of the pSSaS questionnaire provided with permission by Dr ghiassi. The german version of the pSSaS questionnaire provided with permission 
by Dr Miedinger and Dr edelmann.
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curves cross within sensitivity 80–100%, the corrected partial 
AUCs for sensitivity 80–100% are given as well. For each 
ROC curve, the “optimal” cutoff value, that is, the score yield-
ing the highest combination of sensitivity and specificity, and 
the cutoff value with the highest specificity for a given sen-
sitivity of at least 80% (“80% sensitivity”) were determined. 
The 95% confidence intervals of AUCs, sensitivities and 
specificities were determined using a bootstrap resampling 
method (k=10000). To get a more accurate estimate of the 
model performance, an internal validation was performed. An 
ordinary bootstrap resampling procedure (k=1000) following 
the recommendations of Steyerberg et al was applied.24 Each 
pSSAS scoring scheme was validated on the full data set and 
on all four patient groups. As a measure of discrimination, 
bias-corrected Somers’ D
xy
 rank correlation is presented. D
xy
 
corresponds to 2*(AUC–0.5) and thus ranges from 0 (random 
predictions) to 1 (perfectly discriminating predictions). As 
a measure of calibration, we present the calibration slope. 
This is the corrected slope of the overall logistic calibration 
equation observation
i
 ∼ prediction
i
. It can be thought of as a 
shrinkage factor, accounting for overfitting. Well-calibrated 
models have a slope of 1. Finally, as a measure of the overall 
accuracy, we present the Brier score. It represents the average 
prediction error and ranges from 0 (perfect model) to 0.25 
(useless model). Test–retest reliability of the pSSAS after 
a certain time without initiating treatment for OSAS was 
estimated using either Spearman’s rank correlation coef-
ficient (items 1–6 and total pSSAS score) or the proportion 
of identical scores (items 7 and 8). All statistical analyses 
were performed using R (R Core Team, 2014, version 3.0.1). 
The R package pROC was used for all analyses and figures 
of ROC curves.25 Internal validation was done using the R 
package rms (R Core Team, 2013, package version 3.6.3).
Results
Demographic and baseline characteristics
Eleven patients with one or more missing answers were 
excluded (group A =0, group B =5, group C =5, group D =1). 
The full data set consisted of 431 individuals: patient group 
A=234 (54.3%), group B=82 (19%), group C=79 (18.3%), 
and group D=36 (8.4%) individuals. Clinical data, question-
naire and results of sleep studies can be seen in Table 2. 
Prevalence of OSAS and mean body mass index (BMI) was 
highest in the groups A and B. The groups A–C consisted of 
mainly male individuals.
Table 1 pSSaS scoring schemes
pSSAS item Scoring
1–4 Daytime sleepiness 0, 1, 2, 3 and 4 points with 
increasing score indicating 
increasing daytime sleepiness
5 Body size 0, 1, 2, 3 and 4 points with 
increasing score indicating 
increasing body size
6 Neck size 0, 1, 2, 3 and 4 points with 
increasing score indicating 
increasing neck size
7 Blood pressure Normal =0 point
Normal with antihypertension 
medication or high blood pressure 
=4 points
Do not know =0 point (for 
scoring scheme 1), 2 points (for 
scoring scheme 2) and 4 points 
(for scoring scheme 3)
8 Sleep apnea Normal breathing =0 point
Breathing pauses do occur =4 
points
Do not know =0 point (for 
scoring scheme 1), 2 points (for 
scoring scheme 2) and 4 points 
(for scoring scheme 3)
Abbreviation: pSSaS, pictorial Sleepiness and Sleep apnoea Scale.
Table 2 Demographic and baseline characteristics according to patient group
Group A Group B Group C Group D All p-value
Male sex 163 (70%) 55 (67%) 44 (56%) 18 (50%) 280 (65%) p=0.03
OSaS diagnosis 171 (73.1%) 47 (57.3%) 11 (13.9%) 4 (11.3%) 233 (54.1%) p=0.0005
age (years) 46.6 (17.8) 51.9 (16.0) 36.7 (21.0) 43.2 (18.5) 45.5 (21.0) p<0.0001
BMi (kg/m2) 33.6 (10.1) 30.7 (7.7) 26.3 (6.0) 25.1 (4.7) 31 (8.9) p<0.0001
ahi (events/hour) 26.5 (31) 18.2 (20.8) 6.9 (6.0) 3.2 (4.0) 19.4 (24.5) p<0.0001
ODi (events/hour) 20.8 (24.0) 24.5 (23.0) 4.3 (4.0) 2.7 (3.0) 17.0 (21.0) p<0.0001
eSS (points) 10.9 (8.0) 10.0 (8.0) 7.3 (4.0) 6.9 (4.0) 9.7 (7.0) p<0.0001
Sa-SDQ (points) Na 41.8 (12.0) 29.3 (9.0) 27.7 (10.5) 33.9 (13.0) p<0.0001
Notes: group a: Patients examined for OSaS at charing cross hospital, london; group B: patients examined for OSaS at the Sleep clinic of the Barmelweid clinic, 
Switzerland; group c: patients with injuries admitted to the emergency Department at the University hospital Basel, Switzerland; and group D: outpatients referred to the 
Surgical Outpatient or the Occupational Medicine Department at the University hospital Basel, Switzerland. Data are presented as frequency (%) or median (interquartile range). 
p-values for equivalence of all groups were calculated using Fisher’s exact test or Kruskal–Wallis test.
Abbreviations: OSaS, obstructive sleep apnea syndrome; BMi, body mass index; ahi, apnea–hypopnea index; ODi, oxygen desaturation index; eSS, epworth Sleepiness 
Scale; Sa-SDQ, Sleep apnea Scale of the Sleep Disorders Questionnaire; Na, not available.
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Development and validation
The frequency distributions of the three pSSAS scor-
ing schemes according to OSAS diagnoses can be seen in 
Figure 2. For each scoring scheme, there was a considerable 
overlap between positive and negative OSAS diagnoses. The 
predictive performance of the three different pSSAS scoring 
schemes is shown in Table 3. Overall, the diagnostic perfor-
mance of pSSAS scoring scheme 1 was slightly better than 
the scoring schemes 2 and 3 (Table 4 and Figure 3A and B). 
The sensitivity is between 0.670 and 0.839 and specificity 
is between 0.579 and 0.812 depending on the chosen cutoff 
(between 12 and 14 points).
However, none of the three pSSAS scoring schemes 
achieved the aim of discriminating negative and positive 
OSAS diagnoses with a sensitivity and specificity of 80% 
each. As sensitivity was given more weight than specificity, 
an additional cutoff value was determined – 80 se cutoff 
value – which corresponds to the cutoff value with the highest 
specificity for a given sensitivity of at least 80% (Table 3). 
This is in accordance with the ROC analyses described in 
the previous section (Figure 3A and B). The discriminatory 
properties, that is, the ability to distinguish high-risk indi-
viduals from low-risk individuals, of the three pSSAS scoring 
schemes varied between the data sets. They were best in the 
full analysis set (groups A–D) with pSSAS scoring scheme 
1 (D
xy
=0.61, which corresponds to an AUC of 0.81; Table 
3). Discrimination using the scoring scheme 1 was worst in 
patient group C (D
xy
=0.34). The calibration of all pSSAS 
25
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Figure 2 Frequency distribution of the pSSaS questionnaire scores for individuals according to OSaS diagnosis.
Notes: White = individuals with OSaS; black = individuals without OSaS; gray = overlap of the columns. 
Abbreviations: pSSaS, pictorial Sleepiness and Sleep apnoea Scale; OSaS, obstructive sleep apnea syndrome.
Table 3 Predictive performance of the three different pSSaS scoring schemes
AUC Cutoff Value Sensitivity Specificity
Score 1 0.805 (0.763–0.847) Optimal 14 0.670 (0.609–0.730) 0.821 (0.768–0.874)
80 sensitivity 12 0.822 (0.770–0.870) 0.647 (0.579–0.711)
Score 2 0.794 (0.752–0.837) Optimal 12 0.839 (0.791–0.887) 0.579 (0.505–0.647)
80 sensitivity 12 0.839 (0.791–0.887) 0.579 (0.505–0.647)
Score 3 0.774 (0.730–0.819) Optimal 14 0.761 (0.704–0.813) 0.658 (0.589–0.726)
80 sensitivity 13 0.796 (0.743–0.848) 0.584 (0.516–0.653)
Notes: AUC, sensitivity and specificity of the best cutoff value and lowest cutoff value with a minimal sensitivity of 80% are given. 95% bootstrap confidence intervals are 
given in parentheses.
Abbreviations: pSSaS, pictorial Sleepiness and Sleep apnoea Scale; aUc, area under the receiver operating characteristic curve.
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scoring schemes was very good in the full analysis set and 
in patient groups A and B (Table 4; calibration slope closely 
around 1). The worst calibration was found for pSSAS scor-
ing scheme 2 applied to patient group D (slope=1.5). These 
differences can be explained by the differences in the size of 
the data sets. The pSSAS scoring scheme 1 performed rather 
well in patient groups C and D (slope=1.05). Brier score dif-
fered notably between the data sets and was quite high for 
patient group B (B around 0.2; Table 4). Lowest Brier scores 
were observed in patient group D (B around 0.1).
Internal consistency was evaluated by pairwise cor-
relation of pSSAS items (Figure 4). The pSSAS items 1–4 
evaluate EDS. While a rather strong correlation was found 
for pSSAS items 1 (“likeliness of falling asleep while sitting/
reading”) and 3 (“sitting quietly after having eaten”; Spear-
man’s rank correlation coefficient ρ=0.6), the other items 
correlations were only weak or moderate. The pSSAS items 
5 (body size) and 6 (neck circumference) correlated strongly 
(ρ=0.7). Construct validity was investigated by correlating 
pSSAS items or scores with other established measures for 
EDS or OSAS risk: the pSSAS subscore “excessive daytime 
sleepiness” correlated strongly with ESS total score (ρ=0.8; 
Figure 5). Items 5 (body size) and 6 (neck circumference) 
correlated strongly with BMI (ρ=0.8) and measured neck 
circumference (ρ=0.5), respectively. With data from patient 
groups B–D, the correlation of the pSSAS subscore of items 
5–8 “risk factors and adverse outcomes” with total SA-
SDQ score was determined. The different scoring schemes 
resulted in a correlation score of ρ=0.5 for all scoring 
schemes (1, 2 and 3) with SA-SDQ total score (Figure 6).
Twenty-six individuals completed the pSSAS for a second 
time prior to undergoing any treatment for OSAS. The median 
number of days between the tests was 13.5 days (range 0–90 
days). Items 1–6 showed quite strong correlations between 
test and retest scores, ranging from ρ=0.6 (item 1) to ρ=0.9 
(item 4). For item 7 (blood pressure), the consistency between 
test and retest (percentage of identical answers) was 58%. 
For item 8 (witnessed apnea during sleep), the consistency 
between test and retest was 73%. Test–retest correlations of 
pSSAS subscore “excessive daytime sleepiness”, pSSAS 
subscore “risk factors and adverse outcomes” and the total 
pSSAS score were ρ=0.8, ρ=0.7 and ρ=0.7 for the pSSAS 
scoring schemes (1, 2 and 3), respectively (Figure 7).
Discussion
A tool for quantification of EDS is essential in sleep medi-
cine, and the ESS is widely used. However, self-completion 
may be problematical for those with impaired health literacy, 
and a pictorial translation of the Epworth score has been 
demonstrated to produce comparable results.18,20 The pSSAS 
showed good predictive performance with an AUC between 
0.77 and 0.81 depending on the scoring scheme used. The 
subscores of the pSSAS had a moderate-to-strong correlation 
with widely used screening questionnaires for OSAS or EDS 
like the SA-SDQ or the ESS, respectively. The pSSAS showed 
good retest reliability for most of the individual items, the 
subscores and the total score.
Given the limited availability of full-night-attended sleep 
studies, an easy-to-administer instrument that allows quanti-
fication of EDS and identification of individuals with a high 
risk for OSAS would be a useful tool in clinical medicine, and 
several written questionnaires or tools exist, some to be self-
completed and others physician administered.25,26 However, 
when using tools such as questionnaires, we must acknowl-
edge that patients may struggle to understand the meaning of 
the questions or be unable to read. Ghiassi and Partridge have 
shown that 16% of patients attending a London sleep center 
showed impaired health literacy when investigated with the 
Rapid Estimate of Adult Literacy in Medicine (REALM) 
tool.15 This finding was surprising as all the patients admitted 
using English as their everyday language. The authors offer 
two explanations for the low REALM scores: the fact that 
a significant proportion of these patients were non-native 
English speakers or that cognitive defects associated with 
undiagnosed OSAS and EDS could have contributed to this 
result. An impairment in logical memory test results was pre-
Table 4 internally validated performance of all three pSSaS 
scoring schemes for the full data set and for each patient group
Data set pSSAS scoring 
scheme
Dxy Calibration 
slope
Brier score
Full 1 0.61 1.01 0.18
2 0.59 1.00 0.19
3 0.55 1.01 0.19
a 1 0.49 1.01 0.17
2 0.50 1.01 0.17
3 0.50 1.02 0.17
B 1 0.50 1.04 0.21
2 0.51 1.07 0.20
3 0.49 1.07 0.21
c 1 0.34 1.05 0.12
2 0.38 1.26 0.12
3 0.39 1.24 0.12
D 1 0.40 1.05 0.11
2 0.56 1.50 0.11
3 0.60 1.32 0.10
Notes: Dxy =bias-corrected Somers’ Dxy rank correlation. group a: Patients 
examined for OSaS at charing cross hospital, london; group B: patients examined 
for OSaS at the Sleep clinic of the Barmelweid clinic, Switzerland; group c: 
patients with injuries admitted to the emergency Department at the University 
hospital Basel, Switzerland; and group D: outpatients referred to the Surgical 
Outpatient or the Occupational Medicine Department at the University hospital 
Basel, Switzerland.
Abbreviation: pSSaS, pictorial Sleepiness and Sleep apnoea Scale.
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viously shown in patients with OSAS.16 It has been estimated 
that in primary schools in England, one in nine children do 
not speak English as the first language.27 Therefore, a short 
and easy-to-complete questionnaire is needed. Ghiassi et al 
have shown that a pictorial version of the Epworth Sleepi-
ness Scale was rated very easy to complete and preferred 
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to the original version by respondents.17 However, even 
though the ESS is often used to screen for OSAS, it was not 
developed for this purpose and has its limitation. Bloch et 
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Figure 4 Pairwise correlation of pSSaS items 1–6.
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axes indicating the score points (0–4) of the items. 
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Figure 5 correlation of pSSaS “excessive daytime sleepiness” subscore with eSS score.
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al evaluated the ESS in a German population in 1999 and 
found a relatively weak correlation of the ESS scores with 
the respiratory disturbance index.22 This suggests that the 
ESS needs to be combined with other predictors or measures 
to be more useful in screening populations for OSAS. Other 
questionnaires such as the SA-SDQ are more extensive and 
complex and include items on body weight, age, sex, smok-
ing status as well as sleep disturbances. However, due to the 
SA-SDQ’s complexity and length, not all items are always 
completed especially if the questionnaire is filled in by the 
patient itself without supervision and the possibility to clarify 
questions. In the original validation study of this question-
naire by Douglass et al, only 94% of items were completed 
by the respondents.23
The three pSSAS scoring schemes performed equally on 
the full data set and on the four patient groups separately, and 
hence, none of the three scores can be declared as best. Per-
formance differed between the four patient groups, but there 
was no distinct pattern when looking at all three measures 
D
xy
, slope and B. Discrimination (D
xy
) and calibration was 
best in patient group A, while overall accuracy B was best 
in patient group D. The performance on the full data set can 
be summarized as fair to good. The diagnostic performance 
of pSSAS scoring scheme 1 was slightly better than the 
scoring schemes 2 and 3. None of the three pSSAS scoring 
schemes proved to be superior. However, we suggest using 
the scoring scheme 1 given its superior performance in the 
overall sample investigated in our study. We suggest using 
a cutoff of 14 points with a sensitivity of almost 70% and a 
specificity of >80%. A cutoff of 12 points in our population 
increased sensitivity to >80% but decreased specificity to 
64%. Despite its frequent use to screen patients for OSAS, 
the conventional ESS has been shown to have low sensitivity 
and moderate specificity (sensitivity 38–53% and specificity 
59–78%) in individuals having EDS and being investigated 
with polysomnography or polygraphy.28,29
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The pSSAS sleepiness component correlated strongly 
with the ESS. This is in accordance with the original valida-
tion study of the pESS where an acceptable level of equiva-
lence and comparable total ESS scores were obtained between 
the two questionnaires.17 pSSAS items 5 and 6 require self-
assessment of body size and neck size. There was a high cor-
relation of body size with BMI but only moderate correlation 
of neck size with measured neck circumference. It has been 
shown that misclassification of weight and obesity status can 
occur if adolescents are asked to self-report height, weight 
and weight perception.30 However, it is unclear why the cor-
relation between self-assessment of neck size and measured 
neck size is worse as compared to body size.
In a subset of patients from Switzerland, we performed 
test–retest analysis of pSSAS item, subscore and total score. 
Patients filled in the questionnaire on the first day of the 
evaluation for OSAS before any measurements were made. 
However, some of these individuals were aware of blood 
pressure and even sleep study results the second time the 
questionnaire was answered. Therefore, we cannot exclude 
that this new information led to a different answering pattern 
when the pSSAS was filled in the second time. The correla-
tion of responses was moderate or even high for the items 
forming the sleepiness component and the items on body and 
neck size. Test–retest was previously performed in a sample 
of patients investigated in the UK. The correlation coefficient 
for the sleepiness and risk components as well as the total 
score was similar to the Swiss patients.18
For this study, we considered OSAS to be clinically 
relevant in individuals with AHI 5–15 events/hour and sig-
nificantly increased daytime sleepiness equivalent to an ESS 
score of ≥10. We considered an individual to have clinically 
significant OSAS if during the sleep study an AHI ≥15 was 
determined. Individuals with lower AHI (AHI ≥5) but with 
clinically important daytime sleepiness (ESS ≥10) were also 
considered to have OSAS as these patients may be considered 
candidates for interventions such as lifestyle modifications, 
weight reduction, positional therapy or maybe even a CPAP 
treatment trial.31,32 However, there is ongoing debate about the 
management of patients with mild OSAS.33,34 In our opinion, 
the decision to investigate further with objective sleep studies 
or to start treatment should always be based on individual 
risk factors and patient preferences.
Trained board-certified sleep specialists or pneumologists 
according to relevant scoring rules without knowledge of the 
individual pSSAS scores rendering differential bias unlikely 
performed scoring of the sleep studies. However, due to the 
different setting in the three sleep centers in terms of organiza-
tion, devices used for the sleep studies and the fact that sleep 
studies were scored by different persons, observer bias cannot 
be fully excluded. The original form of the pSSAS used in 
UK patients did not allow individuals to choose “don’t know” 
when asked about apneas during sleep. This answering option 
was added to the German version of the pSSAS. Therefore, 
different scoring schemes were only validated in a subset of 
the patients. To assign a diagnosis of OSAS, we considered 
EDS measured with the ESS and the results of the full-night-
attended polysomnography. The ESS is regularly used to mea-
sure and rate the severity of EDS in all three study centers. We 
decided to use a transparent and widely recognized definition 
for OSAS that we could apply to all data sets regardless of 
the health system or practice of care. However, the first part 
of the pSSAS (items 1–4) is very similar to the conventional 
ESS where patients need to rate the probability to fall asleep 
in standard situations. The situation that parts of the test under 
study are partially included in the reference standard could 
lead to an overestimation of the pSSAS diagnostic accuracy.
As a next step, one could evaluate if different cutoff scores 
according to sex or age of the patient increase the diagnostic 
properties of the pSSAS, and if the results of validity and the 
use of the pSSAS in individuals with measured low health 
literacy are as good as in our unselected population. Further, 
one should investigate if the pSSAS score is responsive to 
treatment interventions, and it should be made available for 
other languages and tested in other clinical settings.
The pSSAS is a novel tool that can be used to screen 
individuals with EDS in an outpatient clinic in English- and 
German-speaking setting. Its simple structure, scoring rules 
and the use of pictograms make it an alternative to more 
complex and long questionnaires in clinical practice and 
in patients with impaired literacy. The validation study has 
shown good internal consistency, repeatability and construct 
validity when compared with established tools for the diag-
nosis of EDS and OSAS. However, further research is needed 
to evaluate its responsiveness to therapy and its use in other 
settings such as population screening or self-administration 
without supervision.
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Supplementary material
Translation for the german version 
of the pictorial Sleepiness and Sleep 
apnoea Scale
Three German native speakers with very good knowledge 
of the English language independently translated the text 
of the English version of the pictorial Sleepiness and 
Sleep Apnoea Scale. The individual translations were then 
reviewed by DM. Differences in translation were then 
addressed at a consensus meeting, and an easily understand-
able style and wording was chosen that reflects the meaning 
of the original version as closely as possible. In the German 
version, a third answer option “don’t know” represented by 
a question mark besides “breathing normally when asleep” 
and “stopping breathing when asleep” for question number 
8 was added.
Scoring of sleep studies
Patients investigated at the Imperial Sleep Centre at Charing 
Cross Hospital, London, and Barmelweid Clinic, Barmelweid, 
underwent either polysomnography or polygraphy, whereas 
all patients investigated at the University Hospital in Basel 
underwent polysomnography. In all centers, Embla/Embletta 
Systems (Embla Systems, Broomfield, CO, USA) were used. 
Experienced sleep technicians or physicians scored sleep 
studies. Apnea was defined as an airflow limitation of >90% 
of baseline. Hypopnea was defined as a reduction of airflow 
by at least 30% and followed by saturation drop of at least 
4% from baseline during at least 10 seconds.
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